Highest-materiality recent filing
Ensign Group boosts share repurchase authorization to $100 million
Board approved $60M increase to prior $40M buyback; total authorization now $100M.
Ensign Group Board authorizes $40M stock repurchase program
Board approved $40M share repurchase program starting after current program expires.
Ensign Group shareholders elect all four director nominees and ratify auditor
Class I directors Smith (47.4M for), Abbott (47.8M), Snapper (48.6M) elected; Class II director Pison (50.6M for) elected.
Ensign Q1 diluted EPS $1.67 (+21.9% YoY), revenue $1.39B (+18.4%); raises 2026 guidance
GAAP diluted EPS $1.67, adjusted EPS $1.85; net income $99.7M, adjusted $110.2M; all up ~22-24% YoY.
Ensign Group reports record FY2025 results; GAAP EPS $5.84, revenue $5.06B; issues 2026 guidance
GAAP diluted EPS $5.84 for FY2025 (+14.1% YoY); Q4 EPS $1.61 (+18.4% YoY).
Ensign Group Q3 GAAP EPS $1.42, adjusted EPS $1.64; raises FY25 guidance
GAAP diluted EPS $1.42 (+6.0% YoY); adjusted diluted EPS $1.64 (+18.0% YoY).
Founder and Chairman Christopher Christensen retires effective Sept 1, 2025; no disagreement with company.
Ensign Group Q2 beats, raises FY2025 EPS and revenue guidance
GAAP diluted EPS $1.44 (+18% YoY); adjusted EPS $1.59 (+20.5% YoY).
Christopher Christensen to retire as Executive Chairman and from the Board effective September 1, 2025.
Ensign Group Announces Results of 2025 Annual Meeting of Stockholders
Elected Class II director Mark V. Parkinson with 49,110,416 votes for, and Class III directors Ann S. Blouin (47,727,307), John O. Agwunobi (49,240,959), Barry R. Port (49,332,141).
Ensign Group Q1: GAAP EPS $1.37, adj. EPS $1.52; raises full-year guidance
GAAP diluted EPS $1.37 (+15.1% YoY); adjusted EPS $1.52 (+16.9% YoY); net income $80.3M.
Ensign reports FY2024 GAAP EPS $5.12 (+40.3% YoY); issues 2025 guidance $6.16-$6.34
GAAP net income $298M (+42.3% YoY); adjusted EPS $5.50 (+15.3% YoY).
Ensign Group Q3 EPS $1.34 (adj. $1.39), revenue $1.08B +15%, raises FY24 guidance
GAAP net income $78.4M (+22.8%); adjusted net income $81.1M (+17.7%). GAAP diluted EPS $1.34, adjusted $1.39.
Ensign Group appoints former AHCA/NCAL CEO Mark Parkinson to Board of Directors
Mark Parkinson appointed to fill expanded Board vacancy (9th director), effective Oct 21, 2024.
Ensign Q2 EPS $1.22, adj. $1.32; revenue $1.04B up 12.5% YoY; raises FY2024 guidance
GAAP diluted EPS $1.22, adjusted EPS $1.32; net income $71.0M (+11.0% YoY).
Class II directors Christensen (44.9M for) and Shaw (43.9M for) elected; 3.78M broker non-votes.
Ensign Group Q1 EPS $1.19 adjusted $1.30; revenue $1.01B (+13.9% YoY); reaffirms FY guidance
GAAP diluted EPS $1.19 (+13.3% YoY); adjusted EPS $1.30 (+15.0% YoY); net income $68.8M (+15.0%).
Ensign Group Q4 adjusted EPS $1.28 (+16.4% YoY); FY2024 guidance $5.29-$5.47
GAAP diluted EPS $0.38 Q4, $3.65 FY; adjusted EPS $1.28 Q4 (+16.4% YoY) and $4.77 FY (+15.2% YoY).
Ensign Group Q3 2023 GAAP EPS $1.11, adjusted EPS $1.20; raises FY 2023 guidance
GAAP diluted EPS $1.11 (up 12.1% YoY); adjusted diluted EPS $1.20 (up 15.4% YoY).
Ensign Group board sets annual say-on-pay votes through at least 2029
Stockholders voted for an annual advisory vote on executive compensation at the May 18, 2023 meeting.
Ensign Group Q2 EPS $1.12, adj EPS $1.16; raises FY2023 guidance
GAAP net income $64.0M, adj net income $66.3M; GAAP diluted EPS $1.12, adj EPS $1.16 (+14.9% YoY).
Ensign Group shareholders approve authorized share increase to 150M at annual meeting
Approved amendment to increase authorized common shares from 100M to 150M (51,091,599 for, 508,753 against).
Ensign Group Q1 EPS $1.05, revenue $886.8M; raises FY2023 guidance
GAAP diluted EPS of $1.05, up 18.0% YoY; adjusted EPS of $1.13, up 14.1% YoY.
Q4 GAAP EPS $1.06, adjusted $1.10; FY GAAP $3.95, adjusted $4.14 (+13.7% YoY).
Ensign Group appoints John Agwunobi to board; Lee Daniels resigns Jan 1, 2023
Lee Daniels resigns effective Jan 1, 2023 after serving since 2013; was Compensation Committee Chair.
Ensign Group Q3 2022 EPS $0.99 GAAP, $1.04 adjusted; raises FY2022 guidance to $4.10-4.18
GAAP diluted EPS $0.99, up 19.3% YoY; adjusted EPS $1.04, up 14.3% YoY.
Ensign Group Q2 2022 EPS $1.01, revenue $732.5M, raises annual guidance
GAAP diluted EPS $1.01, up 16.1% YoY; adjusted EPS also $1.01, up 13.5% YoY.
Ensign Group shareholders elect directors, ratify auditor, approve say-on-pay and 2022 equity plan
Class I director Suzanne Snapper elected (42.7M for, 5.6M against); Class III directors Daniels, Blouin, Port elected with over 45.7M for each.
Ensign Group Q1 GAAP EPS $0.89, adj. EPS $0.99; revenue up 13.5% to $713.4M; reaffirms FY guidance
GAAP diluted EPS $0.89 (+3.5% YoY); adjusted diluted EPS $0.99 (+13.8% YoY).
Ensign Group upsizes credit facility by $250M to $600M, extends maturity to 2027
Total facility increased to $600M from $350M; maturity extended to April 8, 2027.
Ensign Group Q4 GAAP EPS $0.86, adj. EPS $0.97; FY2022 guidance $4.01-$4.13
GAAP diluted EPS $0.86 for Q4 (+4.9% YoY); adjusted diluted EPS $0.97 (+21.3% YoY). Full-year GAAP EPS $3.42, adjusted $3.64.
Ensign Group Q3 adjusted EPS $0.91 record, raises 2021 guidance, announces captive REIT formation
GAAP diluted EPS $0.83 (+7.8% YoY); adjusted EPS $0.91 (record, +16.7% YoY).
Ensign Group director Roy Christensen retiring Dec 31, 2021; CFO Suzanne Snapper appointed to board
Roy Christensen retires as director effective Dec 31, 2021; remains Chairman Emeritus as consultant.
Ensign Q2 GAAP EPS $0.87 (+19.2% YoY), rev $638.5M (+9.2%); raises FY guidance
GAAP diluted EPS $0.87, up 19.2% YoY; adjusted diluted EPS $0.89, up 14.1%.
the Board, at the recommendation of the Nomination and Corporate Governance Committee, appointed Barry Port to serve as the Chair of the Board.
the Board appointed Marivic S. Uychiat to fill the vacancy created by Mr. Christensen’s resignation.
Christopher Christensen announced his decision to retire from the Board of directors and as Executive Chairman, effective on September 1, 2025.
appointed Mark Parkinson to fill the vacancy
Lee A. Daniels announced his decision to resign from the Board effective on January 1, 2023 to focus on other endeavors.
the Board appointed John O. Agwunobi, M.D., to fill the vacancy created by Mr. Daniel’s resignation.
Mr. Roy Christensen announced his decision to retire as a director effective December 31, 2021.
the Board appointed Suzanne D. Snapper to fill the vacancy created by Mr. Christensen’s retirement.
Max materiality 0.85 · Median 0.75 · Most common event earnings